Delfi Limited P34
SGX · Singapore · Consumer Non-Durables
SGD 0.7000-0.01 (-0.71%)
Market closed· · SGD · Data may be delayed
Prices may be delayed and are for informational purposes only - not investment advice.
Market closed· · SGD · Data may be delayed
Prices may be delayed and are for informational purposes only - not investment advice.
NEW YORK, September 02, 2026--Members 1st Federal Credit Union invests in Delfi to bring AI-native balance sheet intelligence and capital markets execution to credit unions.
NEW YORK, August 27, 2026--Delfi returns to FinovateFall 2026 to unveil Delfi Exchange and Delfi Agent, connecting balance sheet analytics directly to execution.
NEW YORK, August 07, 2026--Delfi appoints Glen Fossella as CRO to expand AI-native balance-sheet intelligence and capital market execution for community banks and credit unions.
NEW YORK, July 30, 2026--Delfi joins Circuit Accelerator to bring agentic AI balance sheet decisioning and capital markets tools to credit unions and their finance teams.
SLB agrees to acquire Tachyus to add AI-powered reservoir optimization tools, expanding its digital portfolio and strengthening recovery-focused solutions.
DELFI Diagnostics, Inc., developer of AI-powered, blood-based tests for cancer detection, today announced it has received a Clinical Laboratory Permit and Test Approval letter from the New York State Department of Health (NYSDOH). With this permit, DELFI is now authorized to offer its FirstLook™ Lung laboratory-developed test (LDT) in New York. The test is now available in all 50 U.S. states.
DELFI Diagnostics, Inc., developer of innovative AI-powered blood-based tests that leverage cell-free DNA (cfDNA) fragmentomics for cancer detection and monitoring, today announced the appointment of Charles "Charlie" Newton to its Board of Directors. Mr. Newton brings nearly three decades of healthcare finance and executive leadership experience to DELFI as the company reads out pivotal data that advances its lead product, FirstLook™ Lung, toward FDA submission and positions it for broad commer
Delfi Limited's ( SGX:P34 ) stock was strong despite it releasing a soft earnings report last week. However, we think...
The total number of digital subscriptions of AS Ekspress Grupp increased by 6% in the Baltic States year-over-year (1st quarter: -3%) and totalled 237 136 at the end of March. The number of digital subscriptions of AS Delfi Meedia that publishes the news portal Delfi, newspapers Maaleht, Eesti Ekspress and several popular magazines increased by 8% year-over-year (1st quarter: -3%) and totalled 121 407.The number of digital subscriptions of AS Õhtuleht Kirjastus, 50% of which is owned by Ekspress
Recent third-party headlines about this company, kept separate from Makkler's own editorial coverage and linking out to the publisher. Accuracy is the publisher's responsibility.